Z9. COVID-19 Special populations (e.g. pregnant women, children, immunocompromised, etc)
Poster Session: COVID-19: Special Populations
Ousseny Zerbo, PhD
Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, CA, United States
Julius Timbol, MS
Data Analyst
Kaiser Permanente Vaccine Study Center
Oakland, CA, United States
John R. Hansen, MPH
Group Leader Consulting
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Kristin Goddard, MpH
Sr. Research Project Manager
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Evan Layefsky, BA
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Pat Ross, BA
Research Associate
Kaiser Permanente Vaccine Study Center
Oakland, CA, United States
Bruce Fireman, MA
Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Dao Nguyen, MD
Kaiser Permanente Northern California
San Jose, California, United States
Tara L. Greenhow, MD
Regional Lead
Kaiser Permanente Northern California
San Francisco, CA, United States
Nicola P. Klein, MD, PhD (she/her/hers)
Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States